This suggested that the changing trend of IL-1β was opposite to that of depression and anxiety symptoms, indicating that the change of IL-1β could reflect the curative effect to a certain extent in MDD patients with effective antidepressant treatment. Here, IL1B is linked to depressive symptom measurement.